Investing in Vaxcyte Inc (PCVX) Is Getting More Attractive

In a filing, Vaxcyte Inc revealed its CHIEF EXECUTIVE OFFICER PICKERING GRANT unloaded Company’s shares for reported $1.0 million on Mar 25 ’24. In the deal valued at $66.93 per share,15,000 shares were sold. As a result of this transaction, PICKERING GRANT now holds 477,847 shares worth roughly $30.79 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, GUGGENHIME ANDREW sold 8,000 shares, generating $552,144 in total proceeds. Upon selling the shares at $69.02, the PRESIDENT AND CFO now owns 95,679 shares.

Before that, Cowan Elvia sold 11,678 shares. Vaxcyte Inc shares valued at $865,070 were divested by the SVP, FINANCE at a price of $74.08 per share. As a result of the transaction, Cowan Elvia now holds 12,480 shares, worth roughly $0.8 million.

Mizuho initiated its Vaxcyte Inc [PCVX] rating to a Buy in a research note published on December 07, 2023; the price target was $69. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid April with a ‘”an Outperform”‘ rating. Needham also remained covering PCVX and reiterated its “Buy” recommendation on January 03, 2023. Guggenheim started covering the stock on December 15, 2022. It rated PCVX as “a Buy”.

Price Performance Review of PCVX

On Tuesday, Vaxcyte Inc [NASDAQ:PCVX] saw its stock fall -3.45% to $64.43. Over the last five days, the stock has lost -2.92%. Vaxcyte Inc shares have risen nearly 2.60% since the year began. Nevertheless, the stocks have risen 77.64% over the past one year. While a 52-week high of $82.04 was reached on 02/28/24, a 52-week low of $34.11 was recorded on 01/05/24. SMA at 50 days reached $71.12, while 200 days put it at $56.52. A total of 0.87 million shares were traded, compared to the trading of 0.73 million shares in the previous session.

Levels Of Support And Resistance For PCVX Stock

The 24-hour chart illustrates a support level at 63.77, which if violated will result in even more drops to 63.11. On the upside, there is a resistance level at 65.61. A further resistance level may holdings at 66.79. The Relative Strength Index (RSI) on the 14-day chart is 36.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.49%. Stochastics %K at 14.40% indicates the stock is a buying.

How much short interest is there in Vaxcyte Inc?

A steep rise in short interest was recorded in Vaxcyte Inc stocks on Mar 15, 2024, dropping by -2.06 million shares to a total of 8.59 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 10.65 million shares. There was a decline of -23.98%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 8.80% of the overall stock float, the days-to-cover ratio (short ratio) fell to 10.79.

The most recent change occurred on November 17, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $69 price target.

Most Popular